We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mathematical Model Yields Clues to Sickle Cell Disease

By Biotechdaily staff writers
Posted on 16 Apr 2003
Researchers have developed a mathematical model of sickle cell disease in an effort to understand why the mutant hemoglobin proteins form long, stable scaffold-like structures that damage red blood cells rather than less harmful compact crystals.

The mutated form of hemoglobin in individuals with sickle cell disease does not remain in solution in the cytoplasm. Instead, it tends to coagulate into long fibers. A sickle hemoglobin fiber can be made up of anywhere from 14 to more than 400 individual strands of hemoglobin molecules linked into long chains.

Researchers at the University of Warwick (UK) constructed the mathematical molecule to explain the stability of these fibers. The model, which was published March 28, 2003, in the online edition of Physical Review Letters, indicated that an inherent "twistiness” in the strands that comprise the fibers could be the key to their durability.

The authors proposed a possible treatment for sickle cell disease based on their model. Gene therapy might be used to introduce a hemoglobin mutant that would form less-twisty individual strands, and this could turn the fibers into less harmful crystals. Simply introducing normal hemoglobin has been shown not to work, perhaps because the few normal hemoglobin molecules cannot eliminate the fibers.



Related Links:
University of Warwick

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
16 Apr 2003  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
16 Apr 2003  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
16 Apr 2003  |   BioResearch